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The possibility of expanding memory or cognitive capabilities above the levels in high
functioning individuals is a topic of intense discussion among scientists and in society
at large. The majority of animal studies use behavioral endpoint measures; this has
produced valuable information but limited predictability for human outcomes. Accordingly,
several groups are pursuing a complementary strategy with treatments targeting synaptic
events associated with memory encoding or forebrain network operations. Transcription
and translation figure prominently in substrate work directed at enhancement. Notably,
the question of why new proteins would be needed for a now-forming memory given
that learning-driven synthesis presumably occurred throughout the immediate past has
been largely ignored. Despite this conceptual problem, and some controversy, recent
studies have reinvigorated the idea that selective gene manipulation is a plausible
route to enhancement. Efforts to improve memory by facilitating synaptic encoding
of information have also progressed, in part due of breakthroughs on mechanisms
that stabilize learning-related, long-term potentiation (LTP). These advances point to a
reductionistic hypothesis for a diversity of experimental results on enhancement, and
identify under-explored possibilities. Cognitive enhancement remains an elusive goal, in
part due to the difficulty of defining the target. The popular view of cognition as a collection
of definable computations seems to miss the fluid, integrative process experienced by
high functioning individuals. The neurobiological approach obviates these psychological
issues to directly test the consequences of improving throughput in networks underlying
higher order behaviors. The few relevant studies testing drugs that selectively promote
excitatory transmission indicate that it is possible to expand cortical networks engaged by
complex tasks and that this is accompanied by capabilities not found in normal animals.
Keywords: cognitive enhancement, learning, long term potentiation, ampakine, synaptic plasticity, BDNF, F-actin,
positive AMPA receptor modulators
INTRODUCTION
The present review concerns three topics, two of which involve
terms—enhancement and cognition—that are not sharply
defined. Usage of the former seems straightforward when applied
to memory, although it is often unclear whether accelerated
acquisition or an increase in encoding strength is intended. But
applied to cognition, claims for enhancement face the great prob-
lem of how to quantify something for which there is no consensus
measurement system. The difficulty can be reduced by focusing
on cognitive activities of a type that can be described in compu-
tational terms. This, however, raises questions about the extent
to which the sampled process is representative, or a major com-
ponent, of cognition as the term is typically used. In response, it
could reasonably be argued that cognition is a collection of semi-
independent operations (e.g., categorization, value assignment)
(Sugrue et al., 2005; Tsunada and Sawaguchi, 2012) but this seems
unsatisfactory because the phenomenon is experienced as being,
if not unitary, then at least strongly coherent. Electrophysiological
and brain imaging results showing coordinated activity across
broad stretches of neocortex provide some support for the idea
of a system that, while capable of periodically focusing on spe-
cific tasks, usually works by integrating a vast amount of disparate
material into a product accessible to consciousness. A true cogni-
tive enhancer might therefore take the form of a treatment that
increases the speed or capacity of this assembly process.
Memory enhancement, as suggested, appears to be a much
more tractable problem. Retention is easily measured as is the
amount of training needed to produce a given score in a test sub-
sequent to learning. But a curious problem emerges here: few of
the many pharmacological agents that produce robust enhance-
ment of memory in animals are found to have positive effects in
humans. This observation has become the subject of intense pub-
lic discussion, perhaps with growing skepticism about the utility
of animal studies on memory enhancement. Some neuroscien-
tists have argued that the “failure to predict” problem reflects the
widespread use of paradigms that have little relevance to human
learning. These workers have devised ingenious protocols that can
be used in rodents and with minor modifications in humans (e.g.,
Bari et al., 2008; Demeter et al., 2008; Eichenbaum and Robitsek,
2009; Zeeb et al., 2009; Demeter and Sarter, 2013). There is every
Frontiers in Systems Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 90 | 1
SYSTEMS NEUROSCIENCE
Lynch et al. Cognition enhancement in normal subjects
reason to assume that these efforts will ultimately narrow the
gap in cross-species comparisons. But there is a more funda-
mental issue from comparative biology that could underlie the
failure-to-predict problem: humans are enormously encephalized
animals and rodents aren’t (neocortex makes up at least 77% of
brain volume in human and just 31% in rat; Stephan et al., 1981;
Swanson, 1995). Encephalization is hypothesized to result in a
shift of functions from lower brain to cortex; from this perspec-
tive, humans may be using networks of a very different kind than
those employed by rodents to solve similar problems.
An alternative to behaviorally based approaches to developing
enhancers would be to focus on the neurobiological substrates of
memory and cognition. This seems feasible in the case of mem-
ory because of the tremendous progress that has been made in
identifying synaptic mechanisms that encode information. There
is no good reason to think that these processes differ significantly
between mammalian species and indeed comparative studies sug-
gest that certain essential elements are evolutionarily ancient
(Crystal and Glanzman, 2013). It follows from this that treat-
ments acting on memory substrates in rodents are likely to have
similar actions in human brain. Cognition again represents a
much more challenging problem. However, the universally held
assumption that cognitive operations arise from the transient
formation of telencephalic networks points to a relatively sim-
ple idea for enhancement. Communication within and between
cortical regions is mediated by glutamatergic transmission; if
so, then agents that augment the release of glutamate, or the
post-synaptic response to it, should facilitate the formation of
cognition’s substrates.
The following sections consider attempts to develop enhancers
via actions on (i) different aspects of the complex machinery
underlying learning-related synaptic modifications, or (ii) com-
munication within and between cortical networks.
MEMORY ENHANCEMENT
Most research on memory enhancement deals with psychological
events that precede the actual encoding of information. There is
for example a very large literature describing attempts, typically
using chemical agents, to increase the speed of learning by mod-
ulating arousal and attention (Lynch et al., 2011). It has become
common to refer to resultant improvements as cognitive enhance-
ment, presumably because key elements of cognition are being
manipulated, but there are reasons to question this assumption
(see below). There is a smaller, but rapidly growing, body of work
directed at the machinery responsible for converting patterns of
afferent activity into the long lasting increases in synaptic strength
assumed to encode specific information. This section evaluates
the latter material.
GENE EXPRESSION AND PROTEIN SYNTHESIS
Work in this area begins with the hypothesis that learning triggers
the transcription or local translation of proteins that serve to con-
solidate the newly acquired memories, something that can take
anywhere from many minutes to hours. Compounds that facili-
tate production of the pertinent RNAs or proteins could accord-
ingly increase the likelihood that recent learning will lead to stable
memory, and there are many reports of such effects (Guzowski
et al., 2001; Plath et al., 2006; Katche et al., 2010, 2012). However,
the basic idea that new protein synthesis is critical to memory for-
mation has been controversial since its introduction more than
50 years ago (Abraham andWilliams, 2008; Gold, 2008). Much of
the dispute revolves around the necessary prediction that protein
synthesis inhibitors will selectively block recently acquired mem-
ory; most papers report this result but others do not, or argue that
observed disruptions to encoding are due to factors unrelated to
synthesis (Routtenberg, 2008; Gold and Wrenn, 2012).
Beyond this, the protein synthesis argument faces certain con-
ceptual problems. Learning is a continuous process in humans,
and likely other mammals, with new encoding occurring many
times a minute, as is evident with episodic memory. People recog-
nize or recall a remarkable number of serial events when queried
after a 90min movie. Unless we make the very unlikely assump-
tion that each item of information is encoded on a different
neuron, it is difficult to see why, after hours of producing pro-
teins needed for consolidation, a given cell would need further
synthesis to stabilize a now forming memory. Along this line, it
has been argued that animals exposed to an enriched environ-
ment which would entail constitutively elevated basal activity, and
thus activity-driven protein synthesis, may not require additional
synthesis to support LTP (Abraham and Williams, 2008) and the
related encoding of hippocampus-dependent memories. There is,
however, a special case in which transcription and/or broadly
distributed translation could be required to securely encode a
specific memory; namely, a circumstance in which continuous
learning of similar material does not precede the new instance.
Under these conditions, consolidation could depend upon pro-
teins generated by the isolated learning episode. Note that this
scenario loosely describes the great majority of animal studies
testing for the contributions of protein synthesis. Certain of these
arguments make relatively straightforward, readily tested predic-
tions. For example, animals with a well-developed learning set
could be given protein synthesis inhibitors after learning a single
problem with or without having dealt with many such problems
in the preceding hours. Such a paradigm can be achieved for rats
using two-odor discriminations. If continual learning obviates the
need for problem-specific synthesis, then the blockers should have
no effect in a group given many trials prior to being introduced
to the new test items.
There is a variant of the translation hypothesis that addresses
the problem of why prior synthesis doesn’t provide a sufficient
supply of proteins for current learning. This involves the ample
evidence for dendritic (local) translation from already in place
mRNAs. One could posit a set of conditions in which new synthe-
sis, even after recent experience, needs to occur post-acquisition
for transfer into long-term storage; e.g., (1) translation occurs
within very small dendritic compartments; (2) such active regions
are only found in the immediate vicinity of recently modified
synapses; and (3) newly formed proteins do not diffuse to any
great degree. These circumstances would reduce the probabil-
ity that proteins from earlier learning would be present at the
large majority of current sites. But “synaptic tagging” experi-
ments, conducted for instances where LTP in hippocampal slices
is blocked by protein synthesis inhibitors, describe results that are
not consistent with these postulates. Specifically, LTP induction at
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one input protects subsequently induced potentiation at a second
input to the same region from the effects of the inhibitor (Frey
and Morris, 1997; Shires et al., 2012). Given the small number
of synapses that generate EPSPs of conventional amplitudes, it
is extremely likely that connections from the two inputs are, for
the most part, located on different dendritic segments. It follows
then that proteins from the first episode must have been synthe-
sized, or traveled, throughout much of the dendritic arborization,
a point that is reinforced by evidence for tagging in the apical den-
drites after stimulation of basal afferents (Alarcon et al., 2006). It
will be noted that these findings align with the broad idea that
continual learning maintains relevant proteins at levels sufficient
for LTP-related plasticity, obviating the need for synthesis after
individual learning events.
The above discussion concerns interpretative issues rather than
the likelihood of achieving enhancement using the transcription /
translation strategy. It may well be the case that increasing within-
cell levels of proteins that support consolidation reduces the
requirements for encoding persistent memories and/or increases
their stability. Signaling from synapses to the nucleus or to local
protein synthesis machinery involves many steps and so is likely
to be a variable and somewhat uncertain process. It would not
be surprising, then, if the ongoing production of memory-related
elements operates at a less than optimal rate even in high per-
forming, normal subjects. In line with this, there are multiple
demonstrations that treatment with compounds that inhibit par-
ticular histone deacetylases, leading to increased transcription of
select gene families, can markedly enhance memory after single
training sessions (Stefanko et al., 2009; McQuown et al., 2011).
Also of interest are the numerous studies showing that selective
phosphodiesterase-4 inhibitors have potent enhancing effects on
memory. Inhibitors of this class (e.g., Rolipram), drive the protein
kinase A—CREB transcription pathway implicated in learning
in a broad array of animals (including invertebrates), and so
is argued to be a very ancient, evolutionarily conserved mem-
ory substrate (Tully et al., 2003; Normann and Berger, 2008).
Evidence that the same results obtain after extensive experience
with similar problems in the recent past, and presumably a great
deal of learning-driven transcription, would constitute support
for there being less than optimal production of proteins needed
for encoding under normal circumstances. This would certainly
encourage the idea that enhanced protein synthesis is a viable
route to augmented memory.
SYNAPTIC PLASTICITY AND MEMORY ENHANCEMENT
Most mechanism-based efforts directed at improving memory
have focused on synaptic plasticity and in particular the long term
potentiation (LTP) effect. Researchers since the late 19th cen-
tury have argued that the enormous capacity of memory is best
explained by assuming that physical encoding of new information
occurs at small numbers of connections between neurons. The
discovery of LTP demonstrated that individual synapses in the
cortical telencephalon do in fact possess the properties expected
for a memory substrate (Bliss and Collingridge, 1993; Lynch,
1998, 2004b; Morris, 2003). The increase in transmission strength
(magnitude of EPSCs) develops quickly, persists for a remark-
able period (weeks at least) (Staubli and Lynch, 1987; Abraham,
2003), and does not disturb already potentiated contacts as likely
required for a high capacity memory system. A very large body of
experimental work has confirmed the tight connection between
LTP and diverse instances of memory (e.g., Roman et al., 1987;
Rioult-Pedotti et al., 2000; Whitlock et al., 2006). Moreover, LTP
is intimately related to the theta rhythm, an oscillation long asso-
ciated with learning (Buzsaki, 2005; Vertes, 2005; Snider et al.,
2013); i.e., five brief (30ms) bursts of high frequency stimulation
pulses (a pattern that mimics “theta bursting” during learning)
prove to be near optimal for inducing extremely stable LTP but
only when separated by the period of the theta wave (Larson
et al., 1986; Capocchi et al., 1992). The reasons for this have been
identified (Figure 1).
These observations suggest the possibility of enhancing learn-
ing with drugs that promote theta activity and correlated bursts
of high frequency discharges. Agents such as physostigmine,
that facilitate central cholinergic transmission, promote the theta
rhythm (Olpe et al., 1987; Hasselmo, 2006) and are reported
to improve learning scores in certain experimental situations.
Notably, drugs of this type are among the few treatments
approved for Alzheimer’s Disease (Clarke and Francis, 2005;
Noetzli and Eap, 2013). However, cholinergic systems perform
varied functions in brain, some of which are homeostatic in
nature. This likely explains why drugs targeting cholinergic
mechanisms have not gained widespread acceptance as plausi-
ble enhancers. Another approach based on theta activity involves
the large hyperpolarizing potentials triggered within target neu-
rons by the short train of theta bursts used to induce LTP. These
after-hyperpolarizing potentials (AHPs), set in motion by cell dis-
charges, persist throughout the duration of the theta train and
serve to counteract the depolarization needed to unblock the
voltage dependent, synaptic NMDA receptors. Influx of calcium
through these receptors, followed by release of the cation from
intracellular stores, triggers the chain of events leading to poten-
tiation (Figure 1). AHPs are mediated by a set of voltage- and
calcium-sensitive potassium channels, prominent among which
is the SK3 channel (Hosseini et al., 2001). The bee toxin apamin
blocks this channel with some selectivity and, as predicted, aug-
ments post-synaptic responses to theta burst trains; this results in
a striking increase in the magnitude of LTP (Kramar et al., 2004).
While a number of studies have found substantial improve-
ments in rodent learning with apamin treatment (Ikonen and
Riekkinen, 1999; Brennan et al., 2008; Vick et al., 2010), this
is not a likely enhancer because of toxicology issues. But given
increasing interest in applications of channel blockers for diverse
clinical problems, the apamin results suggest an intriguing mech-
anistic target for the development of enhancers. It is of note in this
regard that Brain Derived Neurotrophic Factor (BDNF), which
appears to be released from terminals by theta bursts (Balkowiec
and Katz, 2000; Chen et al., 2010b), also reduces AHPs at least
in rats (Kramar et al., 2004). Elevating endogenous levels of
this neurotrophin, which can be achieved by pharmacological
manipulations described later, thus provides another avenue for
enhancement.
Identification of the initial triggers for LTP, as schematized in
Figure 1, pointed to NMDA receptor-mediated calcium influxes
as a logical target for enhancement. The existence of multiple
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FIGURE 1 | Why theta burst stimulation (TBS) is so effective at
inducing LTP. TBS (Larson et al., 1986) mimics a firing pattern found in
cortical neurons during learning (Otto et al., 1991) and elicits a robust,
non-decremental LTP that persists for weeks (at least). (A) (left side). A
single stimulation pulse releases glutamate (black dots) and a partial
membrane depolarization via current flux through AMPA receptors (dotted
line). NMDA receptors do not open because of voltage dependent block
of the ion channel (open circle). (right side) Trains of high frequency
stimulation cause a greater depolarization (light blue) that removes the
channel block and thereby allows current flow through calcium permeant
NMDA receptors. Calcium is the initial trigger for LTP. (B) Intracellular
recording shows that the first theta burst (four pulses at 100Hz) in a
train causes a relatively modest depolarization accompanied by a single
spike; NMDA receptors make a very small contribution to this response.
A second burst administered after a delay corresponding to the period of
the theta wave produces a more profound depolarization with multiple
spikes; this burst response contains a large NMDA receptor mediated
component. Note that each theta burst in the train is followed by a large
after-hyperpolarization (AHP). The AHP, which is largely mediated by
calcium and voltage dependent potassium channels, tends to counteract
the depolarization produced by the burst, thus capping the magnitude of
NMDA receptor responses. (C–E) How the second and subsequent
bursts generate large depolarization and unblock NMDA receptors. (C) A
glutamatergic axon innervates a pyramidal cell dendrite (gray) and a
feedforward, GABAergic interneuron (orange); note that both contacts use
AMPA receptors (red). (D) A first theta burst triggers GABA release from
the interneuron onto the pyramidal neuron thereby producing a
di-synaptic (slightly delayed) IPSC via post-synaptic GABA-A receptors
(orange ellipses); this shunts the EPSCs produced at neighboring
glutamatergic synapses. The released GABA also binds to pre-synaptic,
metabotrophic GABA-B auto-receptors on the releasing interneuron
terminal (purple). (E) The auto-receptors hyperpolarize the GABAergic
terminal and block release, an effect that reaches its maximum at the
period of the theta wave. A theta burst arriving at this time point
generates an excitatory response that is only weakly counteracted by the
opening of post-synaptic GABA-A receptors (see B).
modulatory sites (e.g., for glycine and polyamine) on the recep-
tors suggested a plausible route for building positive allosteric
drugs (Monaghan et al., 2012). Most of this effort has been
directed toward treatments for neuropathology and psychiatric
disorders, most notably schizophrenia and depression (Labrie and
Roder, 2010; Dang et al., 2014), rather than memory enhance-
ment. Perhaps the most widely studied agent of this type is
D-cycloserine, a compound that targets the glycine binding
pocket on the receptor and facilitates channel opening (Sheinin
et al., 2001; Dravid et al., 2010). It has been known for some
time that the site is important for induction of LTP (Oliver et al.,
1990) and, as expected from this, D-cycloserine enhances var-
ious forms of memory in animals (Flood et al., 1992; Baxter
et al., 1994; Tsai et al., 1999; Normann and Berger, 2008; Peters
and De Vries, 2013). There is also evidence that the endogenous
neurosteroid pregnenolone sulfate (Wu et al., 1991), and other
steroid-like substances (Madau et al., 2009), promote the open-
ing of NMDA receptors and facilitate both LTP andmemory. Also
of note, recent work led to discovery of a naturally occurring
cholesterol metabolite that facilitates NMDA receptor currents
through a novel oxysterol modulatory site andmarkedly increases
the magnitude of LTP (Paul et al., 2013). The development of pos-
itive NMDA receptor modulators is clearly a promising area with
regard to enhancement.
Increasing current flux through AMPA receptors results
in greater post-synaptic depolarization and thereby promotes
removal of the voltage block on NMDA receptors. This sug-
gests that increasing AMPA receptor currents should facilitate the
induction of LTP. Tests of this became possible with the inven-
tion of AMPA receptor modulators that freely enter the brain and
increase fast glutamatergic transmission (Lynch, 2004a). The ini-
tial positive modulators were small benzamide compounds but
subsequent work from many laboratories resulted in diverse fam-
ilies of compounds that slow deactivation or desensitization (or
both) of ligand bound AMPA receptors. Here we will refer to
all agents of this type by the term, “ampakines,” used for the
original compounds. Through a series of electrophysiological and
X-ray crystallography studies, the mechanism of ampakine action
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is now fairly well understood. As illustrated in Figure 2, each
subunit of the tetrameric AMPA receptor has two large extra-
cellular domains that form a “clamshell” that closes upon gluta-
mate binding (Sun et al., 2002). Relaxation to the resting state,
and transmitter release, terminates current flow; this process is
referred to as “deactivation.” The four subunits form two dimers,
an arrangement that can be disrupted by ligand binding; under
these conditions the channel closes but the transmitter is retained.
This interesting, high affinity (slow dissociation constant) state
constitutes the desensitized condition of the receptor (Hall et al.,
1993). It was originally thought that desensitization is the normal
route for terminating the EPSC but it now appears that deacti-
vation is responsible for the decay rate of the synaptic response.
The ampakine binding pocket is located at the dimer interface
near the hinge of the clamshell (Jin et al., 2005); this strategic
position explains how ampakines can affect both deactivation
and desensitization (Arai et al., 1996) (Figure 2). Apparently,
the orientation of the compounds within the pocket determines
which of the two processes is most affected. There is overlap
between AMPA and NMDA receptor pharmacology: compounds
widely used to block the former also exhibit high affinity antag-
onism of the glycine modulatory site on the latter (Kessler et al.,
1989). However, the ampakine pocket is distant to the extracel-
lular domain of AMPA receptor antagonist binding and there
is no evidence that these drugs affect NMDA receptor-gated
currents.
Early work established that ampakines enhance both LTP and
memory (Granger et al., 1993; Staubli et al., 1994), results that
have been multiply replicated by different groups (Lynch, 2004a;
Lynch and Gall, 2013). Versions of the drugs that simply slow
deactivation lower the threshold for inducing LTP whereas those
that affect both deactivation and desensitization also raise the
ceiling on the degree of potentiation produced by theta bursts
(Arai et al., 2002). By changing rate constants for both recep-
tor inactivation processes, the latter compounds lead to much
longer EPSCs and thus prolonged NMDA receptor-mediated cal-
cium influxes. This presumably explains their greater potency.
Surprisingly, there appear to have been no studies testing for
FIGURE 2 | Mode of action for positive allosteric modulators of AMPA
receptors (ampakines). (A) Schematic shows two of the four subunits that
comprise the AMPA receptor tetramer in the resting state; the C-tails are not
included. Each subunit has two large extracellular domains that form a
“clamshell” containing the glutamate binding site. The hinge of the structure
is indicated by the double circle. The subunits dimerize at a zone close to the
hinge. The ampakine pocket (star) is strategically located at the dimer
interface adjacent to the two hinges. There are thus four neurotransmitter,
and two ampakine, sites on the full AMPA receptor. (B) Glutamate binding is
accompanied by a closing of each subunits’ clamshell, resulting in opening of
the ion channel and inward flux of current. The receptor then shifts into one
of two configurations; the gray arrows denote the time required for the
transitions in the presence (dotted) and absence (solid line) of an ampakine.
(C) Normally, single transmission events are followed by opening of the
extracellular domains and release of the transmitter, a process referred to as
“deactivation.” The upper trace to the right describes deactivation after a one
ms pulse of glutamate to an excised patch: delivery of the ligand causes a
sharp influx of current that decays after rapid washout. Bound ampakines
slow reopening, resulting in a significant retardation of deactivation (bottom
trace). (D) Prolonged stimulation of the receptor can disrupt the dimer
configuration, leading to a condition in which transmitter remains bound but
the ion channel returns to the closed state (desensitization). The upper trace
to the right describes an instance of this in which glutamate was applied for
500msec. An initial influx of current was followed by decay, despite
continuing presence of the transmitter, to a steady state value about 1/10 of
the peak flux. Ampakines stabilize the dimer configuration and, as predicted,
greatly slow desensitization—current flow continues throughout the 500ms
application of glutamate. The receptor structural dynamics, including
interactions with an ampakine, illustrated here are based on X-ray
crystallography studies (Sun et al., 2002; Jin et al., 2005); physiological data
are from patches taken from hippocampal slices (Arai et al., 1996, 2002; Arai
and Lynch, 1998).
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differential actions of the two functional classes of ampakine on
learning.
Notably, the positive influence of acutely administered
ampakines on memory are reported for aged and young animals
(Granger et al., 1993, 1996; Shors et al., 1995) as well as for a broad
array of species and learning tasks (Lynch, 2004a; Bernard et al.,
2010). Very few effects in human have been published although
one study using a short half-life, deactivation-only drug obtained
evidence for memory enhancement in different tasks including
ones involving complex processing (Ingvar et al., 1997).
LEARNING-RELATED SYNAPTIC MODIFICATIONS AS A TARGET FOR
ENHANCEMENT STRATEGIES
The discovery of LTP (Bliss and Lomo, 1973) greatly simpli-
fied what had already been an extended search for the sub-
strates of memory. An early and critical clue came with electron
microscopic evidence that stable potentiation is accompanied by
changes in the morphology of dendritic spines (Lee et al., 1979,
1980; Chang and Greenough, 1984), an observation recently and
convincingly confirmed by live imaging experiments (Matsuzaki
et al., 2004; Harvey and Svoboda, 2007; Kramar et al., 2012b).
The initial studies also described results suggestive of an increase
in synapse size and there are now data pointing to a similar
effect after LTP (Chen et al., 2007) and learning (Fedulov et al.,
2007). The observed anatomical restructuring implied that induc-
tion events for LTP or memory result in substantial alterations
to the actin cytoskeleton. Tests of this, using a newly devel-
oped in situ method for labeling F-actin in hippocampal slices,
found that theta bursts cause a dramatic increase in the num-
ber of spines with high concentrations of polymerized actin (Lin
et al., 2005; Kramar et al., 2006). The newly formed filaments
proved to be unstable for a period of 5–10min, after which
they were unaffected by depolymerizing agents (Rex et al., 2009,
2010). The experimental question then became one of how the
very brief AMPA and NMDA receptor events that induce LTP
lead to the formation of new actin cytoskeleton. Work using
Fluorescence Deconvolution Tomography for assessing concen-
trations of activated signaling proteins at individual synapses,
along with the use of selective inhibitors, identified multiple,
GTPase-initiated signaling pathways involved in the assembly
and stabilization of actin filament networks following theta burst
stimulation (Kramar et al., 2009; Rex et al., 2009, 2010; Seese
et al., 2012). Particularly relevant to the present topic, these stud-
ies also described membrane receptors that modulate the activity
of cascades leading to the cytoskeletal reorganization required for
consolidation of LTP (Figure 3).
Brief treatments with BDNF partially activate at least two of
the signaling pathways shown in Figure 3 and potently facilitate
FIGURE 3 | Signaling events responsible for reorganizing the synaptic
cytoskeleton and consolidating LTP. The substratemap for LTP stabilization is
largely based on work using hippocampal slices, although some of the steps
have been observed in learning studies. (A) Immunolabeled synapses
surrounding the LTP site as reconstructed using Fluorescence Deconvolution
Tomography (Seese et al., 2013): The green elements reflect immunostaining
for PSD95, a protein that is evenly distributed within post-synaptic densities at
excitatory (glutamatergic) synapses. Phosphorylated (inactivated) cofilin was
immunolabeled with red fluorescence. Co-localization (p-Cofilin/PSD95) results
in yellow labeling. The technique supports counts and size-measures for about
40,000 synapses per image z-stack and 160,000 synapses per slice, and
calculates the number of these synaptic elements that are co-localizedwith the
signaling protein of interest (p-Cofilin in this instance). These values are then
compared for slices that did or did not receive theta burst simulation. (B)
Schematic shows signaling pathways activated at excitatory synapses by theta
burst stimulation. Transmitter receptors i) increase calcium which stimulates
calpain, a spine protease (Perlmutter et al., 1988) that cleaves cross-linking
proteins (blue lines) for the subsynaptic cytoskeleton, and ii) activates synaptic
adhesion receptors belonging to the integrin family (Babayan et al., 2012).
Integrins then engage at least two Rho family GTPases that promote the
assembly of dynamic actin filaments (RhoA to cofilin and myosin) (Rex et al.,
2009) and, over a period of several minutes, branching and stabilization of the
reorganized cytoskeleton. The latter processes involve Rac/Cdc42 signaling to
cortactin and ARP2/3. The synaptic membrane also contains receptors for the
releasable factors adenosine, estrogen, andBDNF (A1,ERB, TrkB, respectively).
These receptors positively and negatively (A1) influence the signaling
pathways, probably at the level of the GTPases. Studies using neutralizing
antisera, genetic manipulations, toxins, and enzyme blockers confirm certain
key links in the model and show that disrupting these specific actin regulatory
pathways blocks the consolidation, but not initial expression, of LTP.
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both theta burst-driven actin polymerization and LTP (Chen
et al., 2006; Rex et al., 2007). It seems likely that the LTP effects
reflect both direct actions on the actin regulatory pathways and
the above noted influence on AHPs generated during the theta
stimulation trains (see above). Notably, scavenging extracellular
BDNF blocks the stabilization of LTP produced by theta burst
stimulation (Kovalchuk et al., 2002; Rex et al., 2007) as well as the
associated activation of actin regulatory signaling and increases
in spine F-actin (Figure 4); activity-induced release of the neu-
rotrophic factor thus emerges as a key ingredient in the normal
production of learning-related synaptic changes. In all, increases
in BDNF signaling appear to be a biologically plausible means
for enhancing memory. Peripheral administration of the pro-
tein is unlikely to have robust central effects but brain permeant
agonists for its synaptic TrkB receptor have been developed and
shown to improve function in varied conditions of impairment
(Andero et al., 2012; Schmid et al., 2012; Ding et al., 2013; Jiang
et al., 2013). Reports on how these compounds affect mem-
ory in normals have only begun to appear but initial studies
indicate that acute systemic treatment can improve object recog-
nition, object location and fear memory when given just before
training (Andero et al., 2011; Bollen et al., 2013); for object loca-
tion memory administration 3 h after training was also effective.
These results encourage the expectation that acute systemic treat-
ment with a TrkB agonist can facilitate both initial encoding and
mechanisms of consolidation for at least some forms of memory.
Further work is needed to determine the range of learning and
cognitive functions that respond to this strategy and if this occurs
without deleterious side effects.
Another route for utilizing BDNF in memory studies is sug-
gested by the observation that transcription of the factor is
positively regulated by neuronal activity (Isackson et al., 1991;
Gall, 1992). It follows from this that increases in excitatory drive
to neurons, as for example produced by ampakines, should up-
regulate the neurotrophin. A sizable number of studies using
individual or a series of daily injections of the positive modula-
tors have confirmed this basic idea (Lauterborn et al., 2000; Rex
et al., 2006; Simmons et al., 2009; Bernard et al., 2010; Haditsch
et al., 2013). The treatments rescue theta burst-induced actin
polymerization and LTP in a number of animal models of human
conditions in which memory loss and/or intellectual disabilities
are prominent, including those for normal aging, low estrogen
FIGURE 4 | BDNF enhances theta burst induced actin signaling and
cytoskeletal assembly at hippocampal synapses. (A) Brief infusion of
BDNF (60 ng/ml) into adult hippocampal slices increases phosphorylation
of PAK and cofilin (immunoblots), two of the signaling proteins included
in the schematic for LTP consolidation (Figure 3). Phosphorylation was
blocked by addition of the extracellular BDNF scavenger TrkB-Fc (applied
at 0.2–2µg/ml). There were no evident effects of either treatment on
levels of total PAK or cofilin. (B) Labeling of filamentous (F-) actin with
fluorescence-tagged phalloidin applied to slices 10min after delivery of
two theta bursts (TBS), a number too small to generate LTP if applied
alone. Pretreatment with BDNF (right image) caused a marked increase
in TBS-induced labeling of dendritic spines relative to labeling in
ACSF-bathed slices receiving similar stimulation. Graph: Summary of the
number of spines with intense concentrations of F-actin, as assessed
using automated counting for a fixed sampling field, confirmed these
observations (CON, slices received low frequency stimulation only;
∗p < 0.01 vs. CON). (C) Similar to (B) except that ten theta bursts
were used. Pretreatment with TrkB-Fc completely blocked the otherwise
robust increase in F-actin positive spines seen with ten burst TBS.
Modified from Rex et al. (2007).
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levels, early stage Huntington Disease, and Angelman syndrome
(Rex et al., 2006; Simmons et al., 2009; Baudry et al., 2012; Kramar
et al., 2012a). When tested, daily injections also reduced or elimi-
nated memory impairments (Simmons et al., 2009; Baudry et al.,
2012). Several weeks of daily ampakine treatment were shown
to be well tolerated. They also markedly reduced pathology and
improved motor functioning in a mouse model of early onset
Huntington Disease (Simmons et al., 2011); subsequent work
with systemic administration of a TrkB agonist obtained similar
results (Simmons et al., 2013).
Although it is apparent that semi-chronic ampakine treat-
ment increases BDNF protein levels, and has potent brain effects
predicted from this, there appear to be no studies testing for
influences of up-regulating BDNF on learning in normal, high
functioning animals. This likely reflects an assignment of greater
importance to treatment than to enhancement with regard
to drug development. But the exciting results obtained with
up-regulation and receptor agonists with regard to brain dis-
orders make BDNF-based strategies one of the more promis-
ing mechanism-grounded approaches to achieving memory
enhancement.
The substrate map for LTP consolidation includes estrogen
receptor beta as a second membrane agent that exerts a powerful
modulatory influence over the actin signaling leading to LTP con-
solidation. Thirty minute infusions of estrogen, at physiological
concentrations, cause a modest increase in baseline transmis-
sion in hippocampus but a striking facilitation of LTP (Cordoba
Montoya and Carrer, 1997; Foy et al., 1999; Bi et al., 2000; Kramar
et al., 2009). Recent work showed that these effects are due to
activation of one of the actin regulatory cascades initiated by
theta bursts (i.e., RhoA>ROCK>LIMK>cofilin—see Figure 3)
and the assembly of new filamentous actin in spine heads (Kramar
et al., 2009). Unlike the case for BDNF, there are several reports
that estrogen improves memory scores in high functioning sub-
jects across tasks and species (Frye et al., 2007; Liu et al.,
2008; Hara et al., 2014). Evidence for similar effects in humans
appears to be lacking (Grodstein, 2013) although several stud-
ies describe a decline in verbal memory with surgical menopause
and improvements with hormone replacement (Brinton, 2009).
Beyond needing further evidence for effects in cognitively normal
individuals, a primary barrier to development of an estrogen-
based enhancement strategy lies in the fact that the steroid affects
many fundamental cellular processes in brain and the periphery,
and is known to facilitate certain types of cancer. More restricted
actions can be had using agonists selective for the hormone’s beta
receptor which is, to a degree, concentrated in brain; such agonists
are highly effective in LTP studies (Kramar et al., 2009). Evidence
that estrogen is synthesized by hippocampal neurons and that
hormone of local origin contributes significantly to hippocampal
synaptic plasticity (Ooishi et al., 2012; Vierk et al., 2012) should
also be noted here. Thus, it may be possible to find means to
promote normal, likely activity-dependent, estrogen actions in a
regionally restricted manner.
INTEGRATION: MANY PATHS TO THE SAME END
Brain scientists had proposed increases in the strength of con-
nections between neurons as the substrate of memory before the
introduction of the word “synapse” (Cajal, 1894). The idea is
intuitively attractive since such increases would clearly alter the
operation of cortical networks and thus behavior. In essence, it
describes microscopic events that, when implemented at many
sites, could be the physical instantiation of the macroscopic phe-
nomenon of memory. From this perspective, the most direct
route to memory enhancement would involve facilitating physi-
ologically produced, long lasting increases in synaptic responses.
Developing what is still only an outline of the machinery that
induces, expresses, and consolidates LTP then shaped ideas about
how to produce facilitation. To some extent, it also led to a uni-
fication that is perhaps under-appreciated: an unrelated array of
enhancement candidates such as steroids, trophic factors, posi-
tive modulators of glutamate receptors, and channel blockers can
now be seen to operate at specific levels within the same cell bio-
logical framework (Lynch et al., 2013). Optimistically, we may
be approaching a reductionistic (simplifying) conceptual event
with regard to enhancing encoding of specific pieces of infor-
mation. Notably, something of this kind may also be going on
for appreciating shared mechanistic impairments present in quite
different disorders that interfere with learning: work with a sizable
number of rodent models suggests that conditions with disparate
etiologies result in a common endpoint failure in cytoskeletal
reorganization (Lynch and Gall, 2013).
But there are warning signs with regard to the possibility that
the current substrate model may be overly tailored to a spe-
cific instance of learning-related plasticity, and in particular to
that found in a particular dendritic lamina (stratum radiatum)
of a particular hippocampal subfield (CA1). Even within that
subfield, there is good evidence that the basal dendritic field
exhibits a different form of LTP (Arai et al., 1994; Kramar and
Lynch, 2003). And it is now well established that the peculiar
mossy fiber connections between dentate gyrus and field CA3
use a form of long lasting potentiation that bears little resem-
blance to that found in apical field CA1 (Staubli, 1992; Schmitz
et al., 2003). It is not unreasonable to expect that additional
plasticity variants will be discovered as parametric studies are
carried out for other telencephalic connections; e.g., the cortico-
striatal glutamatergic synapses (Jia et al., 2010) or the olfactory
and associational afferents to piriform cortex (Jung et al., 1990).
While these observations greatly complicate predictions about the
behavioral effects of putative enhancers, they also offer intrigu-
ing possibilities concerning specificity of action. That is, there
are reasons to think that different forms of synaptic potentiation
may underlie different types, or aspects, of memory. An explicit
proposal of this type has been advanced for the basal and api-
cal dendrites of field CA1 (Arai et al., 1994; Kramar and Lynch,
2003): The easily induced, readily erased LTP in the basal den-
dritic field seems well suited for transient encoding while the
higher threshold and more rapidly stabilized form in the apical
field is more appropriate for long term memory. An arrangement
of this type would be useful in addressing the problem of how
to accomplish, through repeated sampling, low noise extraction
of constancies from a novel environment (apical dendrites) while
at the same time transiently storing a great deal of information
much of which can be discarded as being irrelevant (basal den-
drites). In any event, testing experimental compounds on various
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forms of plasticity could lead to agents that target particular forms
of memory.
COGNITIVE ENHANCEMENT
DOES AUGMENTING MEMORY ENHANCE COGNITION?
Memory is such a prominent part of cognition that it seems obvi-
ous that enhancing the one will improve the other. However,
there may be good computational reasons that cognitive benefit
is gained when acquisition is less than optimal in terms of speed
and strength. Animals faced with new and complex circumstances
need to encode regular features without storing variable, low
information elements. Otherwise, as noted earlier, the resultant
memories will be noisy and less predictive of future encounters.
The spaced trials effect—wherein, temporally separated train-
ing trials more efficiently support encoding than does a single
“massed” session—can be seen as one adaptation toward better
capture of regularities in the learning environment (Hintzman,
1976; Commins et al., 2003; Cepeda et al., 2006). That is, spac-
ing ensures that only elements that are regularly present will be
incorporated into memory while transient features will not. An
enhancer could obviate the need for spacing by producing strong
memory on an initial trial but would be expected to result in a
noisy representation.
Tests of the above point are lacking but LTP experiments have
produced what may be pertinent results. The original descrip-
tions of links between theta burst afferent stimulation and LTP
showed that, absent other manipulations, trains of ten bursts pro-
duced near maximal potentiation (Larson et al., 1986), a result
that led to what has become a standard paradigm. Recently, how-
ever, it was found that a second theta train doubles the level of
potentiation but only if it is delayed by about 60min (Figure 5);
a third stimulation train produces still more potentiation but
only if it is applied at least 60min after the second. Additional
work suggested that this LTP “spaced trials effect” reflects the
presence of a large population of synapses with high plasticity
thresholds that are “primed” by the first theta episode and then
shifted into the potentiated state by the second (Kramar et al.,
2012b). These effects fit naturally within the above described sub-
strate map for LTP: activation of synaptic integrins by a first
theta burst train was followed by an approximately one hour
period before these receptors could be re-engaged by additional
stimulation (Babayan et al., 2012). They also set the stage for a
first test of how a drug that enhances memory affects a phys-
iological analogue of the spaced trials effect. The results were
clear: infusion of an ampakine prior to theta train #1 produced
the expected enhancement in the amplitude of LTP1 but also
occluded further increases in the level of potentiation following
a second, delayed theta train administered in the absence of the
drug (Kramar et al., 2012b). Thus, the ampakine enhanced ini-
tial encoding (as multiply reported) but did so at the expense of
effects of spaced stimulation, and presumably the computational
advantages associated with spacing (Lynch and Gall, 2013 for a
discussion).
The preceding example describes a situation in which phar-
macologically augmenting memory would likely not result in
enhanced cognition, at least in complex environments lacking
explicit guidelines for effective performance. These are routine
circumstances in which demands on cognition are high. But a
great deal of cognition involves instances in which significant
cues and appropriate responses are salient and predetermined,
and irrelevant information is minimized. Under these conditions,
enhanced encoding could be of great use in building or expanding
FIGURE 5 | A “spaced trials effect” for LTP. (A) Theta burst stimulation
(TBS) produces stable LTP. A single train of ten bursts was delivered to one
input to the CA1b recording field after 20min of collecting baseline synaptic
responses to 3/min stimulation pulses in adult rat hippocampal slices. A
second input to the same dendritic region received 3/min pulses throughout
the session. Note that the potentiation of the experimental input did not
decay over 5 h of recording (means ± s.e.m.s for seven slices); traces at right
show representative baseline (black) and potentiated (gray) responses.
(B) Effect of a second theta train (TBS2) applied at various times after TBS1.
TBS2 produced no further increases in the slopes of the responses when
delayed by 10, 30, or 40min after TBS1, but doubled the magnitude of LTP
when applied after a 60min interval. Modified from Kramar et al. (2012b).
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cognitive structures. Thus, the effects of memory enhancement
on cognition could prove to be situationally dependent with clear
benefits in some cases and neutral or even negative influence in
others.
NETWORKS AND COGNITIVE ENHANCEMENT
Discussions of neurobiological processes underlying cognition
inevitably begin with the immensely complicated networks
formed by cortical neurons, if for no other reason than a lack
of realistic alternatives. This fundamental idea suggests two paths
to acute enhancement. First, improving throughput within estab-
lished networks should lead to faster computation and better
utilization of cognitive time. Second, augmented synaptic com-
munication could allow for the transient assembly of larger
than normal networks (e.g., incorporation of additional corti-
cal regions) to deal with a particular problem, and thus the
opportunity to execute more complex or even entirely novel com-
putations. In this sense better throughput would add capabilities,
perhaps the surest measure of cognitive enhancement. Increased
plasticity might add a third route to enhanced cognition by allow-
ing for construction of functional networks that would not likely
emerge under normal conditions; however, as noted in the pre-
ceding section, positive versions of such effects may be limited to
particular circumstances.
There are multiple manipulations that should result in
improved throughput. Communication between collections of
neurons is greatly improved by synchronizing their activity,
something that is accomplished in the cortical telencephalon
by system-wide rhythms. These patterns are induced by diffuse
ascending projections from the lower brain and drugs that affect
these have predictable strong effects on rhythmic activity (Staubli
and Xu, 1995; Kowalczyk et al., 2013). But, as mentioned in
the discussion of memory, the diffuse systems influence a broad
range of brain functions including ones that are vital to survival.
And so, as in the case of memory, they do not represent a promis-
ing avenue toward enhancement in high functioning individuals.
A more likely approach would be to increase transmitter release
or post-synaptic responses to transmitter binding at the gluta-
matergic connections used for the great bulk of intra-cortical
communication.
Adenosine, which depresses glutamate release via presynap-
tic A1 receptors (Dunwiddie and Haas, 1985), is increased in
the extracellular environment during repetitive firing by two
mechanisms: rapid release from post-synaptic neurons followed
by slower release of ATP from glia which is then converted to
adenosine by ecto-5′-nucleotidase, an enzyme located on glial
membranes (Klyuch et al., 2012; Wall and Dale, 2013). These
observations represent a significant part of the tripartite model
(terminal bouton, spine, astrocyte) of fast, excitatory transmis-
sion (Araque et al., 1999). Selective antagonists of the A1 receptor
increase glutamate release in slices and these compounds do
indeed reverse impairments in LTP in slices of middle-aged rat
hippocampus (Rex et al., 2005). However, despite evidence that
the compounds enter the brain (Wall and Dale, 2013), there
has been surprisingly little work on in vivo effects after periph-
eral administration. Perhaps the lack of interest with regard to
network operations reflects understandable concern about the
important roles played by adenosine in the periphery, including
actions on the heart and lungs.
Nicotinic receptors for acetylcholine are also found on glu-
tamatergic terminals where they promote release (Wonnacott,
1997) and there is evidence that this increases network through-
put (Gioanni et al., 1999). Alpha7-containing and alpha4/beta2
subtypes of the receptors both appear to be effective in this regard
(Dickinson et al., 2008). However, the situation is complicated
by the likelihood that compounds targeting nicotinic receptors
act on cholinergic and GABAergic neurons as well (Wonnacott,
1997; Alkondon and Albuquerque, 2001); moreover, it is not clear
that these receptors are present throughout glutamatergic net-
works. In all, nicotinic receptor agonists and positive allosteric
modulators can be assumed to affect portions of excitatory cir-
cuitry in the telencephalon while at the same timemodifying local
processing—via modulation of cholinergic input, interneurons,
and glutamatergic collaterals—at individual relays. Net effects
will be complex but there is good evidence that the compounds
acting on frontal networks enhance “top-down” mechanisms for
focusing attention (Sarter et al., 2009). Since pertinent drugs
are already in clinical trials (Holmes et al., 2011; Demeter and
Sarter, 2013), nicotinic compounds, and especially those target-
ing the alpha4/beta2 receptor subtype concentrated in brain, have
to be seen as one of the most promising of current approaches to
cognitive enhancement.
The ampakine compounds described in the earlier section on
memory enhancement seem particularly appropriate for improv-
ing communication within and between cortical regions. Their
mode of action has the virtue of relative simplicity: an exten-
sive body of research from many laboratories has not uncovered
any evidence for effects on targets other than AMPA receptors.
And they produce the same facilitation of fast, excitatory trans-
mission after peripheral administration as seen with infusions
into brain slices. Indeed, ampakines appear to be the only agents
so far shown to cause comparable in vitro/in vivo facilitation
of EPSPs. These points lead to two critical experimental ques-
tions. First, does increasing monosynaptic transmission result in
greater output from a polysynaptic network? This might seem to
be a foregone conclusion but each step in a series of neuronal
stations has local processing mechanisms (relays are not passive
transferal points) dominated by an impressive collection of dif-
ferent types of inhibitory interneurons. These inhibitory elements
respond both to inputs directly and to discharges from principle
(glutamatergic) neurons; they also form complex local networks
among themselves. It is therefore possible that strong inputs are
dampened and normalized to a degree such that the second stage
of a network may not pass on a larger than normal signal in
the presence of an ampakine. Second, assuming augmentation
of the signal does occur, what are the functional consequences of
enhanced network throughput?
Brain slices provide for the simplest and most compelling
tests for circuit behavior because anatomically precise stimulation
and recording is possible and extrinsic modulatory (cholinergic,
etc.) inputs (cholinergic, serotonergic, etc.) that might influence
downstream responses are excluded. Work of this kind has estab-
lished that weak facilitation of monosynaptic transmission with
an ampakine results in a greatly amplified response from the
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output stage of the trisynaptic intra-hippocampal circuit (Sirvio
et al., 1996). These observations accord with the broad idea that
facilitated transmission at one connection will lead to a greater
number of cells transmitting to the next. Repeated across many
stages, each responding to the ampakine, this will produce a
multiplier effect for drug action. This argument points to the con-
clusion that ampakine-type drugs will exert much greater effects
in the long chains of glutamatergic neurons that constitute cor-
tical networks than in the much simpler circuits found at lower
levels of the neuraxis. Why the multiplier effect doesn’t ultimately
result in abnormal discharges likely reflects the above mentioned
inhibitory interneurons whose influence on projection neurons
also grows with increasing glutamatergic drive, as seen in input /
output measurements in conventional hippocampal slice exper-
iments. Since inhibition generated by arrival of a glutamater-
gic input is di- (and multi-) synaptic, there is brief widow in
which network facilitation is operative. Sophisticated multi-scale
(biophysics, synapses, neurons, and connectivity) computational
work indicates the manner in which enhanced throughput can
produce useful effects in complex cortical circuits (Bouteiller
et al., 2011). However, the effects of increased EPSPs on network
responses to rhythmic or complex stimulation are a critical and as
yet unstudied issue.
Evidence for enhanced throughput has also been obtained
in studies using in vivo analyses of hippocampal projections to
frontal cortex (Baumbarger et al., 2001) and chronic record-
ings from the output stage of hippocampus (Hampson et al.,
1998b). The latter rat study showed that the number of cells
discharging during key steps in performing a complex task was
substantially increased by systemic treatment with an ampakine
(Figure 6). Given that the recording site was the terminus of the
primary intra-hippocampal circuit, one can reasonably assume
that the observed results reflected an augmentation of drug action
through a polysynaptic network similar to those described for
ampakines infused into hippocampal slices (Sirvio et al., 1996).
But the possibility that augmented excitatory drive on ascend-
ing biogenic amine systems, whether from the drugs or the
behavioral activity they produce, results in generalized increases
FIGURE 6 | Ampakine treatment increases neuronal activity in the
terminal stage of the intra-hippocampal network and this is
accompanied by supra-normal performance on a complex task. (A) Adult
rats were extensively trained in the delayed non-match to sample (DNMS)
task, illustrated here, wherein they were required to sequentially (i) press a
bar to receive a reward (sample phase; left) at which time a light appeared on
the opposite wall of the arena, (ii) move to the wall with the light during the
“delay phase” (top) and perform a nose poke for random intervals until the
light extinguished, and then (iii) return to the original side of the arena and
press the bar that had not been originally selected (non-match phase; right).
The level of success in executing the task reached asymptote after weeks of
training, after which the animals were separated into vehicle or drug treated
groups. Injections were given every other day. Animals given the ampakine
prior to individual training sessions showed a progressive increase in correct
responses over the next 2+ weeks of daily testing, ultimately reaching levels
far higher than the asymptotic level maintained by vehicle-only rats (not
shown; see Hampson et al., 1998b). (B) Chronic recordings from the same
hippocampal neuron collected during task performance prior to and after the
start of drug treatment. As shown, the ampakine dramatically increased the
firing rate most particularly after the initial response to the sample (blue
arrow) and in the delay phase leading up to the non-match choice (red arrow);
this pattern and ampakine-related change was typical of field CA1 cells. (C)
Plot shows the mean firing rate of all units recorded during the delay phase
expressed as a percent of the baseline firing rate (prior to ampakine
treatment): the progressive increase in firing rate in the experimental rats
paralleled the increase in successful trials in the same rats. Rats given vehicle
only (open circles) exhibited no change in cell firing or successful task
execution over the full period of testing. Note that the increased firing in the
drug group was still present on vehicle days (red dots), and indeed for the
week following cessation of treatment, an effect that is interpreted as being
due to facilitation of LTP-type plasticity on drug days. Adapted from Hampson
et al. (1998b).
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in neuronal excitability cannot be excluded in these in vivo
studies.
FUNCTIONAL EFFECTS OF ENHANCED NETWORKS
There are relatively straightforward results showing the effects of
increasing throughput in cortical networks in simple experimen-
tal paradigms. For example, unilateral lesions of the nigro-striatal
projections result in a circling response to dopamine agonists;
ampakines significantly expand activation of the motor cortex
on the side of the lesion and this is associated with a suppres-
sion of rotations (Hess et al., 2003). Note that in this case circuits
are selectively brought into play that are directly germane to the
problem faced by the animal. The expectation of a more subtle
version of this effect under conditions in which cortex is perform-
ing complex calculations constitutes one basis for hypothesizing
that improved network throughput will result in acute enhance-
ment of cognition. It should be noted here that the development
of very fast algorithms for extracting core spatio-temporal activ-
ity patterns from multi-electrode recordings has made it possible
to insert, via stimulation at many sites, information rich patterns
to networks in behaving animals. These advances have opened
the way to experimental testing of fundamental, long-standing
assumptions about how cortical circuits process complex signals
from the environment. One recent study of this kind that is par-
ticularly germane to the present discussion showed that delivery
to CA1 of a “correct” pattern of activation predicted from CA3
recordings during the sample phase of a match to sample problem
markedly enhanced performance of monkeys on the subsequent
decision phase in difficult versions of the task (Hampson et al.,
2013). These dramatic findings encourage the idea that facilitat-
ing partial or “weak” network patterns can lead to pronounced
improvements in the ability of animals, including primates, to
deal with complexity.
As mentioned earlier, enhancement could take the form of
acceleration of cognitive activities, and thus allowing for more
computations in the same time frame, or expansion of networks
and potentially new types of operations. One route for testing
the latter possibility would be to overtrain animals to the point
at which optimal performance is fully established and then to
determine if network facilitation through enhanced transmission
allows the subject to go beyond normal limits. There is very little
work of this kind for ampakines or any other putative enhancer
but suggestive results have been described. The study noted above
in which ampakines expanded the hippocampal response during
learning (Figure 6) also found that overtrained rats significantly
improved their learning scores under the influence of the drug.
Remarkably, the animals then continued to perform at supra-
normal levels in the absence of the ampakine. Detailed analyses
showed that the animals shifted response strategies in a man-
ner that reduced proactive interference between trials (Hampson
et al., 1998a). In essence, the drugs opened the way to expanded
networks and the development of higher order rules that can-
not otherwise be acquired even with weeks of training. Another
example of going well beyond normal limits has been described
for monkeys performing a challenging delayed match-to-sample
problem (Porrino et al., 2005). The animals were trained to
asymptote to identify, as indicated by movement of a computer
cursor, a previously seen real world cue from a group of similar
objects. Performance on the task was increased dramatically with
ampakine pretreatment. Brain imaging studies then uncovered a
remarkable result: the ampakine intensified activity in frontal and
temporal cortices but also led to the engagement of a superior
parietal region, the precuneus, which was inactive during vehi-
cle trials. The precuneus is thought to be critical for envisioning
future actions by humans. In any case, these results in a primate
provide an example in which expansion of cortical networks is
associated with a lifting of limits on performance in a cognitively
demanding problem.
These few studies using overtrained animals, exciting though
the findings may be, are hardly sufficient to establish the general
point that increases in network throughput result in beyond nor-
mal performance on challenging problems. Experiments of this
type are not common because they involve major investments
in time and technology. And it will be noted that they focus on
problems that are sharply defined with regard to cues and appro-
priate responses. One can fairly ask if these conditions capture
the essence of cognition as a free flowing processing of the enor-
mous complexities generated by the exterior and interior worlds
of humans. This point is picked up in the following section.
FUTURE NEUROBIOLOGICAL STUDIES ON COGNITIVE ENHANCEMENT
A question running through this review, and alluded to imme-
diately above, concerns the extent to which we can consider
problem solving by animals as a fair descriptor of cognition. One
can hardly question the proposition that the analyses of different
computations performed by distinct frontal subfields in rats (e.g.,
credit assignment to particular serial actions, set shifting, focusing
of attention; Turner et al., 2004; Sugrue et al., 2005; Demeter and
Sarter, 2013) will provide deep insights into how humans resolve
real world issues. But here we encounter the problem of how to
define cognition and whether or not it can be understood in sim-
ple computational terms. To be specific, what might be needed are
studies testing whether putative enhancers improve the perfor-
mance of sophisticated (highly experienced) subjects dealing with
novel circumstances of great complexity and without the benefit
of external supervision. If nothing else, this would bring exper-
iments closer to the human condition and thereby help explain
why animal studies on cognition and memory have such a poor
record in predicting human outcomes.
Much of the present discussion centered on the proposition
that enhancing network throughput will have positive effects
on cognition (Figures 7A,B). It will be recognized that most
of the material presented in support of this idea dealt with
specific neuronal circuits or opportunistic discoveries of net-
work expansion. A more systematic, agnostic description of how
experimental compounds affect the vast number of forebrain
circuits is badly needed. This could be obtained using activity-
regulated immediate early gene expression to provide an index
of the recent history of neuronal firing. Such analyses would
provide a picture of the networks assembled to deal with com-
plex circumstances, surely an initial step toward a mechanism
based theory of cognitive operations, and add an informa-
tion rich step for the screening of experimental compounds.
There is also the possibility that network maps of drug effects
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FIGURE 7 | Mapping as an endpoint measure for evaluating the effects
of putative enhancers. Schematic illustration of a dorsal view of the left
side of a rodent brain, with an open outline of the olfactory bulb at top and
the cerebellum at bottom. Gray is for control subjects while green denotes
results obtained in the presence of an experimental treatment. (A–C)
Network Mapping. The figures describe the distribution of cells activated
during learning of a novel environment, as could be determined from maps
assembled from serial sections labeled for activation of Immediate-Early
Genes (see text). Combining this information with neuroanatomy (red lines)
would provide a picture of the extent to which known circuits were engaged
during learning. (A) Interaction with the environment increases the number
of cells firing (red dots) in three successive stages of a transcortical
network, resulting in output from the third stage. A fourth region that that is
weakly innervated by preceding network stages (dotted line) is not
engaged. (B) A compound that facilitates excitatory synaptic transmission
increases the number of neurons that respond to the input and thereby
reduces circuit-throughput time (< x ms) and generates a more robust
network output. (C) An additional possibility, supported by experimental
work, is that improved transmission adds regions to the network, resulting
in novel outputs (“out #2”). Potentially, the cortex in this instance would
gain new capabilities for dealing with complex problems. (D–F) Mapping of
encoding sites (engrams). Recent advances have made it possible to
identify synapses that are modified by recent learning. Mapping studies for
hippocampus strongly suggest that such effects are restricted to a small
number of sites in a multiple stage network (see text). (D) Under control
conditions, memory-related synaptic changes, such as LTP, are restricted to
stage #2 (yellow dots, asterisk) of one network engaged during learning.
(E) An enhancer could increase the number of neurons on which such
synaptic changes occur in regions in which they are normally found (double
asterisks). Such an effect is predicted to result in the formation of stronger
memory (e.g., more resistant to extinction). (F) Improved transmission
relating to an experimental treatment reduces the threshold for inducing
memory-related synaptic alterations such as LTP. It follows from this that
the manipulation could result in synaptic modifications in regions at which
they do not normally occur (multiple asterisks). This is predicted to produce
an elaborated, novel representation of the learned material.
would be predictive: measures of intensified activity within, or
expansion of, behaviorally engaged circuits (Figure 7C) should
lead to explicit hypotheses about the origins of psychological
changes.
Another type of mapping may also prove useful in future
searches for cognitive enhancers (Figures 7D–F). As noted,
changes in the numbers of individual synapses associated with
LTP-related actin regulatory proteins have been detected in hip-
pocampus following learning. Notably, the labeled synapses were
larger than their neighbors (Fedulov et al., 2007), an effect that
was also seen with LTP (Chen et al., 2007). Continuing advances
in the technology for identifying synapses engaged in plastic
changes that underlie learning have made it possible to plot the
distribution, across entire cross-sections of the hippocampus, of
subfields that reliably contain many such contacts. A first study
using the mapping method to plot synapses undergoing plastic-
ity following learning of a new environment detected only three
out of forty-two sampling zones within hippocampus that match
this description; imposing a response contingency that interfered
with free exploration eliminated the effect (Cox et al., 2014).
These results cannot be taken as indicating that learning related
synaptic adjustments only occur within these three sites; it is
entirely possible that such effects are present in many regions but
vary between subjects and/or are not numerically large enough
to be detected with current procedures. But the results strongly
suggest that encoding of one type of spatial information is not
homogeneously distributed but instead occurs at high levels in a
surprisingly small number of locations. In essence, they constitute
a first, albeit crude memory map that covers one septo-temporal
segment of the hippocampus.
Localizing memory has been a much discussed topic among
brain scientists since the early days of the last century; subsequent
attempts to map the distribution of encoding sites acquired an
evocative title: “The search for the engram” (Thompson et al.,
1976; Thompson and Krupa, 1994). Maps, or engrams, are of
evident importance to the development of neurobiological theo-
ries of how memories are recalled but they are also of potential
significance with regard to network events related to cognitive
enhancement. The discussion to this point has stressed the effects
of transiently facilitating network throughput but it is noteworthy
that certain of the manipulations suggested for this purpose, such
as increasing neurotrophic factor signaling, may also promote
stable changes in connectivity. But would such changes simply
increase the efficacy (e.g., throughput time) of extant circuits or
would they allow for the emergence of new and persistent net-
works? This distinction returns to the earlier consideration of
enhancement as reflecting faster processing or the introduction
of new capabilities. The technology for mapping the location of
learning-driven synaptic modifications may allow for neurobi-
ological, as opposed to purely behavioral, tests of the question:
does an experimental manipulation intensify the map (more
synapses with LTP-related changes at normal sites) vs. creating
additional regions with high numbers of modified connections
(Figures 7D–F).
In all, a futuristic combination of network mapping with
localization of synaptic changes could shift the evaluation of
putative enhancers from exclusively behavioral endpoints to
the presumed network substrates of cognitive operations. Such
a step would likely lead to the many advantages in problem
conceptualization historically associated with reductionism in
science.
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